Iron injection for addressing Iron deficiency Anaemia.

Iron injection is a next-generation solution for addressing Iron Deficiency Anaemia.The product will be available as Redshot FCM.

Iron injection for addressing Iron deficiency Anaemia.

Ahmedabad: Cadila Pharmaceuticals, a pioneer in the pharmaceutical industry, proudly announces the launch of a novel iron injection, a next-generation solution for addressing Iron Deficiency Anaemia. The product will be available as Redshot FCM, fortified with the advanced Ferric Carboxymallose formulation, designed for administration to both adults and paediatric patients over one year of age, especially those with oral iron intolerance.

 Redshot Injection stands out as an intravenous iron preparation that not only delivers effective amounts of iron but also boasts an exemplary safety profile. With superior tolerability and minimal to zero risk of anaphylaxis, Redshot accelerates the improvement of haemoglobin levels and efficiently replenishes depleted iron stores. Offering heightened tolerability, the intravenous delivery of iron in  Redshot facilitates the utilization of high doses in a single administration.

Anaemia, characterized by impaired physical activities, general weakness, lethargy, and fatigue, often goes  unnoticed and is inadequately managed, particularly in pregnancy,the elderly population, and cancer patients. Remarkably, Redshot addresses this gap, as anaemia is prevalent in cancer patients and has been linked to lower survival rates for those grappling with this deficiency. Anaemia in pregnancy, if not treated, can complicate childbirth and can put mothers and neonates at serious risks.

Dr. Rajiv I. Modi, Chairman, and Managing Director of Cadila Pharmaceuticals, stated, “This innovation exemplifies our commitment to pharmaceutical excellence, contribution to the safe  motherhood  initiative, and correction of a very common health condition of iron deficiency anaemia. It not only offers superior tolerability but also presents a transformative approach to replenishing iron stores rapidly and efficiently.”

Cadila Pharmaceuticals remains committed to advancing healthcare solutions and is proud to bring Redshot Injection to the forefront, offering a transformative approach to combating Iron Deficiency Anaemia. With its innovative formulation and enhanced safety features, Redshot marks a significant leap  forward in the treatment landscape, ensuring a brighter and healthier future for patients worldwide.

Also Read: Women in India suffers most from Anaemia

Share this:

shugreek diabetes tablets-medifield

 

 

Share this:

Jodarin-pain-cream

 

 

Share this:

Magazines

SUBSCRIBE MAGAZINE

Click Here

error: Content is protected !!